JOHN ESTES: Open Payments
NPI 1811586779 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 45 payments from 9 companies in 2025. Trend: 2023 $410 · 2024 $548 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $163 |
| Orexo US, Inc. | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Indivior Inc. | 3 | $95 |
| Braeburn Inc. | 3 | $65 |
| Exact Sciences Corporation | 2 | $36 |
| Amgen Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, MAVYRET, Zubsolv, REXULTI, SUBLOCADE, BRIXADI, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
